Jazz Pharmaceuticals PLC (JAZZ)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 560,120 | 414,832 | -214,139 | -328,954 | 238,616 |
| Total assets | US$ in thousands | 12,012,300 | 11,393,400 | 10,835,300 | 12,298,600 | 6,535,900 |
| ROA | 4.66% | 3.64% | -1.98% | -2.67% | 3.65% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $560,120K ÷ $12,012,300K
= 4.66%
The return on assets (ROA) of Jazz Pharmaceuticals PLC has exhibited fluctuations over the years based on the provided data. As of December 31, 2020, the company achieved a ROA of 3.65%, indicating that it generated $0.0365 in net income for every dollar of assets held. However, by December 31, 2021, the ROA turned negative at -2.67%, implying that the company incurred a loss in relation to its assets.
Subsequently, as of December 31, 2022, the ROA remained negative at -1.98%, suggesting continued challenges in effectively utilizing its assets to generate profits. The trend reversed in the following period, with a notable improvement in the ROA to 3.64% by December 31, 2023, indicating better efficiency in utilizing assets to generate income.
The most recent data point, as of December 31, 2024, shows a further increase in ROA to 4.66%, reflecting an improvement in profitability relative to its asset base. Overall, the company's ROA performance has been mixed, signaling periods of both profitability and challenges in generating returns from its assets. Continued monitoring and analysis of ROA trends will be crucial to assess the company's operational efficiency and overall financial performance.
Peer comparison
Dec 31, 2024